Recall Weekly
Serious riskFDA DeviceClass I

Arrow International thoracentesis kits recalled for sterility risk

Arrow International included anesthetic medications (lidocaine and bupivacaine) and saline solution from a supplier with quality issues in multiple drainage, thoracentesis, and pneumothorax kits. If these injectable products lost sterility during manufacturing or storage, they could cause serious infection or treatment failure.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your facility has any of the affected kit models: AK-01600, AK-01601, ASK-01601-MM, AK-01000-T, AK-01000, ASK-01000-CHP, ASK-01000-NW, ASK-01000-UPMS, AK-01500, ASK-01500, or ASK-01500-JCM
  2. Do not use the recalled kits; contact Arrow International or your supplier for replacement or credit
  3. Review lot numbers (beginning 33F or 33R) on packaging to confirm if your stock is affected
Official notice ↗

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Description/REF: DRAINAGE KIT/AK-01600, DRAINAGE KIT/AK-01601, DRAINAGE KIT/ASK-01601-MM, THORACENTESIS KIT/AK-01000-T, THORACENTESIS KIT/AK-01000, THORACENTESIS KIT/ASK-01000-CHP, DRAINAGE KIT/ASK-01000-NW, THORACENTESIS KIT/ASK-01000-UPMS, PNEUMOTHORAX KIT/AK-01500, PNEUMOTHORAX KIT (NO HEIMLICH VALVE)/ASK-01500, PNEUMOTHORAX KIT/ASK-01500-JCM
Sold in
Nationwide
Made for
All ages (under 100 years)

This recall covers 35 products — see all of them.

Details

Units affected
444,943
Illnesses reported
None reported
Manufactured in
3015 Carrington Mill Blvd, Morrisville, NC, United States
Classification
Class I
Recall number
Z-2382-2026

In the FDA's words

Description
Description/REF: DRAINAGE KIT/AK-01600, DRAINAGE KIT/AK-01601, DRAINAGE KIT/ASK-01601-MM, THORACENTESIS KIT/AK-01000-T, THORACENTESIS KIT/AK-01000, THORACENTESIS KIT/ASK-01000-CHP, DRAINAGE KIT/ASK-01000-NW, THORACENTESIS KIT/ASK-01000-UPMS, PNEUMOTHORAX KIT/AK-01500, PNEUMOTHORAX KIT (NO HEIMLICH VALVE)/ASK-01500, PNEUMOTHORAX KIT/ASK-01500-JCM Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries. REF(Material)/UDI-DI/Lot(Batch): AK-01600/50801902120156, 10801902193275, 50801902120156, 60801902120160/33F24A0376, 33F24A1008, 33F24C0091, 33F24D0067, 33F24E0321, 33F24G0322, 33F24L0062, 33F24L0811, 33F24M0267, 33F25C0101, 33F25C0988, 33F25E0035, 33F25H0010, 33F25J0819, 33F26B0492, 33F24A0044; AK-01601/60801902120160, 10801902193275, 10801902190915/33F24A0783, 33F24A1070, 33F24C0092, 33F24E0322, 33F24G0323, 33F24J0273, 33F24L0651, 33F25C0102, 33F25C0916, 33F25E0036, 33F25G0078, 33F25J0460, 33F25L0371, 33F24B0427; ASK-01601-MM/10801902125726, 10801902193275, 10801902125726, 10801902205909/33F24F0656, 33F24K0319, 33F24M0166, 33F25A0163, 33F25E0587, 33F25G0164, 33F25L0116, 33F26A1377, 33F26C0174, 33F24F0213; AK-01000-T/10801902145120, 10801902193275, 10801902194029/33F24C0090, 33F24D0066, 33F24E0319, 33F24G0320, 33F24K0085, 33F24L0792, 33F25C0872, 33F25E0033, 33F25J0459, 33F25L0367, 33F24A0015; AK-01000/10801902197952, 10801902193275, 10801902197952, 10801902145120/33F24A0017, 33F24A0018, 33F24A0348, 33F24A0349, 33F24A0350, 33F24A0351, 33F24A1005, 33F24A1006, 33F24D0005, 33F24D0006, 33F24D0007, 33F24D0008, 33F24D0009, 33F24D0010, 33F24D0011, 33F24D0012, 33F24E0032, 33F24E0033, 33F24E0034, 33F24E0035, 33F24E0036, 33F24E0037, 33F24E0038, 33F24E0041, 33F24E0042, 33F24E0167, 33F24E0168, 33F24E0169, 33F24E0170, 33F24E0171, 33F24G0319, 33F24G0567, 33F24G0568, 33F24J0487, 33F24J0673, 33F24K0084, 33F24K0308, 33F24K0312, 33F24L0626, 33F24L0726, 33F24L0782, 33F24L0787, 33F25A0454, 33F25A0611, 33F25A0612, 33F25C0100,33F25C0211,33F25C0905,33F25C0954, 33F25E0032,33F25E0286, 33F25E0287, 33F25E0908, 33F25E1063, 33F25E1064, 33F25G0076, 33F25G0157, 33F25H0008, 33F25H0188, 33F25H0189, 33F25H0190, 33F25H0191, 33F25H0192, 33F25J0458, 33F25J0740, 33F25J0741, 33F25J0788, 33F25J0799, 33F25J0800, 33F25K0250, 33F25K0251, 33F25K0360, 33F25K0361, 33F25K0362, 33F25K0363, 33F25L0019, 33F25L0020, 33F25L0100, 33F25L0101, 33F25L0268, 33F25L0485, 33F25L0487, 33F25M0831, 33F25M0860, 33F26A0217, 33F26A0218, 33F26A0693, 33F26A0988, 33F26B0505, 33F26B0506, 33F26C0574, 33F24A0794; ASK-01000-CHP/10801902193275, 30801902120190, 10801902203134/33F24G0228, 33F24J0192, 33F24K0020, 33F24L0021, 33F24L0523, 33F24M0063, 33F25B0010, 33F25B0061, 33F25B0132, 33F25C0405, 33F25D0198, 33F25H0277, 33F25H0810, 33F25J0995, 33F26A1273, 33F26B0695, 33F24E0388; ASK-01000-NW/10801902193275, 10801902114867/33F24G0390, 33F24K0153, 33F25B0693, 33F25C0873, 33F25H0051, 33F25J0854, 33F25M0921, 33F24A0645; ASK-01000-UPMS/10801902114867, 10801902193275/33F24B0805, 33F24C0930, 33F24D0683, 33F24H0186, 33F24L0214, 33F24L0912, 33F25B0542, 33F25D0325, 33F25D0527, 33F25F0156,33F25J0099, 33F25J0196, 33F25L0270, 33F26A1392, 33F24G0276; AK-01500/10801902194029, 10801902193275, 50801902120156/33F24E0044, 33F24E0172, 33F24E0173, 33F24G0321, 33F24G0569, 33F24J0488, 33F24K0086, 33F24K0573, 33F24L0724, 33F25A0455, 33F25C0722, 33F25D0126, 33F25E0034, 33F25E0909, 33F25G0077, 33F25G0549, 33F25H0009, 33F25H0720, 33F25J0818, 33F25L0384, 33F26B0535, 33F26C0263, 33R24E0044, 33F23K0711; ASK-01500/10801902156232, 10801902193275, 30801902120206/33F24A0777, 33F24C0130, 33F24E0391, 33F24G0392, 33F24J0542, 33F24L0765, 33F25C0127, 33F25C0735, 33F25E0105, 33F25H0053, 33F25J0495, 33F25L0335, 33F24A1274; ASK-01500-JCM/30801902120206, 10801902193275, 10801902125726 Distribution: US Nationwide distribution including in the states of VA, NY, UT, SC, LA, MN, PA, AZ, CA, MI, OH, FL, CT, KS, IL, TX, WI, GA, NC, MD, OR, AK, NH, IA, ND, OK, NM, AL, MA, KY, WA, AR, CO, IN, ME, TN, WY, NJ, SD, MS, MO, MT, DE, ID, NE, WV, RI, VT, NV, HI, DC, PR. Affected quantity: 444,943
Hazard
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

35 products in this recall

Arrow kits with lidocaine and bupivacaine recalled for sterility risk

Arrow is recalling 35 kits and sets that contain lidocaine, bupivacaine, or 0.9% sodium chloride from a supplier that was itself recalled for quality issues. If the sterility of these water-based injectable drugs is compromised, it could lead to serious or life-threatening injuries. No injuries have been reported, and the products were distributed nationwide.

The agency lists each product separately. Check every one you might have.

Related topics

OtherSterilityMedical devicesSold nationwideMore from FDA Device